Učitavanje...
Trastuzumab Beyond Progression in Retrospective Analyses: An Issue of Equal Opportunities
Results of the Hermine study of trastuzumab beyond progression in breast cancer patients, published by Extra and colleagues in The Oncologist, are re-examined and an alternative explanation for the dismal postprogression survival time of patients stopping therapy is presented.
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AlphaMed Press
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228112/ https://ncbi.nlm.nih.gov/pubmed/21393343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0329 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|